GLOBUS MEDICAL INC Insider Trading Activity
Every SEC Form 4 insider transaction reported for GLOBUS MEDICAL INC (GMED), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are GMED insiders buying or selling?
In the last 12 months, GLOBUS MEDICAL INC insiders reported 0 open-market purchases ($0) and 13 sales ($17.5M) — net selling of $17.5M. Since March 2018, Trabud has recorded 82 Form 4 filings for GMED: 3 buys ($99.8K) and 79 sells ($358.7M).
Source: SEC EDGAR Form 4
What stands out
- No GLOBUS MEDICAL INC insider made an open-market purchase in the last 12 months; the 13 reported open-market sales totaled $17.5M.
Key Statistics (March 2018 – Sep 16, 2026)
Total Form 4 filings
82
SEC EDGAR
Insider filers
16
Insider buys (3)
$99.8K
Insider sells (79)
$358.7M
Insider sentiment
Net sellingNet insider flow of $358.6M in net selling since March 2018, and $17.5M in net selling over the last 12 months.
Recent GMED insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | James R Tobin | Director | Sale | 30.0K | $74.58 | $2.2M | SEC ↗ |
| Aug 19, 2026 | Stephen T Zarrilli | Director | Sale | 25.0K | $87.04 | $2.2M | SEC ↗ |
| Jun 9, 2026 | David D Davidar | Director | Sale | 25.0K | $80.76 | $2.0M | SEC ↗ |
| Feb 27, 2026 | Kelly Huller | EVP, GC, Corporate Secretary | Sale | 20.0K | $94.50 | $1.9M | SEC ↗ |
| Feb 17, 2026 | Kelly Huller | EVP, GC, Corporate Secretary | Sale | 10.0K | $87.67 | $876.7K | SEC ↗ |
| Jan 12, 2026 | Kyle Kline | Senior Vice President, CFO | Sale | 3.6K | $101.10 | $363.4K | SEC ↗ |
| Jan 12, 2026 | Leslie V Norwalk | Director | Sale | 2.0K | $101.10 | $202.2K | SEC ↗ |
| Dec 16, 2025 | Leslie V Norwalk | Director | Sale | 4.0K | $88.85 | $355.4K | SEC ↗ |
| Dec 4, 2025 | Kyle Kline | Senior Vice President, CFO | Sale | 18.5K | $90.00 | $1.7M | SEC ↗ |
| Nov 28, 2025 | Kelly Huller | SVP, GC, Corporate Secretary | Sale | 7.5K | $90.00 | $675.0K | SEC ↗ |
| Nov 13, 2025 | David D Davidar | Director | Sale | 25.0K | $86.00 | $2.2M | SEC ↗ |
| Nov 13, 2025 | Stephen T Zarrilli | Director | Sale | 25.0K | $84.29 | $2.1M | SEC ↗ |
| Nov 10, 2025 | Ann D Rhoads | Director | Sale | 10.0K | $81.80 | $818.0K | SEC ↗ |
| Sep 16, 2025 | Ann D Rhoads | Director | Sale | 10.0K | $58.46 | $584.6K | SEC ↗ |
| Mar 4, 2025 | Ann D Rhoads | Director | Sale | 7.5K | $78.68 | $590.1K | SEC ↗ |
| Jan 14, 2025 | Keith W Pfeil | COO, CFO | Sale | 14.2K | $88.29 | $1.3M | SEC ↗ |
| Dec 4, 2024 | Kelly Huller | SVP, GC, Corporate Secretary | Sale | 2.5K | $87.00 | $217.5K | SEC ↗ |
| Nov 25, 2024 | David D Davidar | Director | Sale | 40.0K | $85.00 | $3.4M | SEC ↗ |
| Nov 25, 2024 | Dan Lemaitre | Director | Sale | 14.4K | $85.00 | $1.2M | SEC ↗ |
| Nov 25, 2024 | Daniel T Scavilla | President, CEO | Sale | 130.0K | $85.00 | $11.1M | SEC ↗ |
| Nov 8, 2024 | Daniel T Scavilla | President, CEO | Sale | 60.0K | $80.02 | $4.8M | SEC ↗ |
| Nov 8, 2024 | Kelly Huller | SVP, GC, Corporate Secretary | Sale | 5.0K | $81.01 | $405.1K | SEC ↗ |
| Oct 18, 2024 | David D Davidar | Director | Sale | 50.0K | $75.04 | $3.8M | SEC ↗ |
| Sep 17, 2024 | Ann D Rhoads | Director | Sale | 15.0K | $70.36 | $1.1M | SEC ↗ |
| Sep 17, 2024 | David D Davidar | Director | Sale | 25.0K | $70.46 | $1.8M | SEC ↗ |
Showing the 25 most recent of 82 Form 4 filings for GLOBUS MEDICAL INC.
Most active GMED insiders
- Kelly Huller16 filings
- David D Davidar11 filings
- Keith W Pfeil9 filings
- James R Tobin7 filings
- David M Demski6 filings
Ask anything about GMED insider activity
Use Trabud's AI agent to query GLOBUS MEDICAL INC's Form 4 history in plain English — "Show me GMED CEO purchases this year" or compare it against any other ticker.
Open the AI agentGMED insider trading FAQ
Are GLOBUS MEDICAL INC insiders buying or selling?
In the last 12 months, GLOBUS MEDICAL INC insiders reported 0 open-market purchases ($0) and 13 sales ($17.5M) — net selling of $17.5M. Since March 2018, Trabud has recorded 82 Form 4 filings for GMED: 3 buys ($99.8K) and 79 sells ($358.7M). Over the full record that is net selling of $358.6M.
How many insiders trade GMED stock?
16 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for GLOBUS MEDICAL INC. The most recent filing was accepted on Sep 16, 2026.
Where does Trabud get GMED insider trading data?
All GMED insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.